Long-Term Outcome of Intact Abdominal Aortic Aneurysm After Endovascular or Open Repair

医学 围手术期 危险系数 腹主动脉瘤 腔内修复术 倾向得分匹配 外科 优势比 置信区间 回顾性队列研究 动脉瘤 队列 主动脉瘤 存活率 内科学
作者
Jasmin Epple,Yuliya Svidlova,Thomas Schmitz‐Rixen,Dittmar Böckler,Neelam Lingwal,Reinhart T. Grundmann
出处
期刊:Vascular and Endovascular Surgery [SAGE Publishing]
卷期号:57 (8): 829-837 被引量:3
标识
DOI:10.1177/15385744231178130
摘要

Endovascular aortic aneurysm repair (EVAR) has been established as a standard treatment option for intact abdominal aortic aneurysm (iAAA) and gained importance due to a lower perioperative mortality than open repair (OAR). However, whether this survival advantage can be maintained or if OAR is beneficial in terms of long-term complications and reinterventions remains questionable.In this retrospective cohort study data from patients undergoing elective EVAR or OAR for iAAAs in the years 2010-2016 was analyzed. The patients were followed through 2018.In the propensity score matched cohorts the perioperative and long-term outcomes of the patients were assessed. We identified 20 683 patients undergoing elective iAAA repair (76.4% EVAR). The propensity matched cohorts included 4886 pairs of patients.The perioperative mortality was 1.9% for EVAR and 5.9% for OAR (P = <.001). The perioperative mortality was mainly influenced by patients age (Odds-Ratio (OR):1.073, confidence interval (CI):1.058-1.088, P ≤ .001) and OAR (OR:3.242, CI:2.552-4.119, P ≤ .001). The early survival benefit after endovascular repair persisted for approximately 3 years (estimated survival EVAR 82.3%, OAR 80.9%, P = .021). After that time the estimated survival curves were similar. After 9 years the estimated survival was 51.2% after EVAR as compared to 52.8% after OAR (P = .102). The operation method didn't influence long-term survival significantly (Hazard-Ratio (HR): 1.046, CI: .975-1.122, P = .211). The vascular reintervention rate was 17.4% in the EVAR cohort and 7.1% in the OAR cohort (P ≤ .001).EVAR has a significantly lower perioperative mortality than OAR, a survival benefit that lasts up to 3 years after intervention. Thereafter, no significant difference in survival was observed between EVAR and OAR. The decision between EVAR or OAR may depend on patient preference, surgeons' experience, and the institutions' ability to handle complications.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
1秒前
酷波er应助钟情紫色短裤采纳,获得10
1秒前
3秒前
酷炫的爆米花完成签到,获得积分10
3秒前
4秒前
5秒前
无无发布了新的文献求助10
5秒前
7秒前
8秒前
李杰发布了新的文献求助10
8秒前
can发布了新的文献求助10
8秒前
Laila发布了新的文献求助10
8秒前
9秒前
迷路如曼发布了新的文献求助10
9秒前
zhou关注了科研通微信公众号
9秒前
9秒前
眼睛大樱桃完成签到,获得积分10
10秒前
CG2021发布了新的文献求助10
10秒前
10秒前
华仔应助科研通管家采纳,获得10
11秒前
11秒前
NexusExplorer应助科研通管家采纳,获得10
11秒前
愔愔应助科研通管家采纳,获得50
11秒前
愔愔应助科研通管家采纳,获得50
11秒前
11秒前
搜集达人应助科研通管家采纳,获得10
11秒前
李健应助科研通管家采纳,获得10
11秒前
搜集达人应助科研通管家采纳,获得30
11秒前
充电宝应助科研通管家采纳,获得10
11秒前
11秒前
11秒前
11秒前
11秒前
Jasper应助科研通管家采纳,获得10
11秒前
11秒前
12秒前
小马甲应助科研通管家采纳,获得10
12秒前
ElioHuang应助科研通管家采纳,获得10
12秒前
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
AnnualResearch andConsultation Report of Panorama survey and Investment strategy onChinaIndustry 1000
機能性マイクロ細孔・マイクロ流体デバイスを利用した放射性核種の 分離・溶解・凝集挙動に関する研究 1000
卤化钙钛矿人工突触的研究 1000
Engineering for calcareous sediments : proceedings of the International Conference on Calcareous Sediments, Perth 15-18 March 1988 / edited by R.J. Jewell, D.C. Andrews 1000
Continuing Syntax 1000
Harnessing Lymphocyte-Cytokine Networks to Disrupt Current Paradigms in Childhood Nephrotic Syndrome Management: A Systematic Evidence Synthesis 700
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6259463
求助须知:如何正确求助?哪些是违规求助? 8081549
关于积分的说明 16885422
捐赠科研通 5331265
什么是DOI,文献DOI怎么找? 2837951
邀请新用户注册赠送积分活动 1815334
关于科研通互助平台的介绍 1669243